Gain Therapeutics CEO Gene Mack to serve as interim CFO
The company said Gene Mack will take over principal financial and accounting duties on an interim basis from Oct. 1, 2026, while it searches for a permanent replacement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.